Arcus Biosciences, Inc. (RCUS): Price and Financial Metrics

Arcus Biosciences, Inc. (RCUS): $16.95

1.22 (+7.76%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add RCUS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#160 of 329

in industry

RCUS Price/Volume Stats

Current price $16.95 52-week high $20.31
Prev. close $15.73 52-week low $12.95
Day low $16.95 Volume 187
Day high $16.95 Avg. volume 723,106
50-day MA $16.61 Dividend yield N/A
200-day MA $16.36 Market Cap 1.55B

RCUS Stock Price Chart Interactive Chart >


Arcus Biosciences, Inc. (RCUS) Company Bio


Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing cancer immunotherapies in the United States. It is developing various products for treating solid tumors, including AB928, an adenosine receptor antagonist that is in Phase I clinical trial; AB680, a CD73 inhibitor; AB122, an anti-PD-1 antibody that is Phase I clinical trial; and AB154, an anti-TIGIT antibody. The company was founded in 2015 and is based in Hayward, California.


RCUS Latest News Stream


Event/Time News Detail
Loading, please wait...

RCUS Latest Social Stream


Loading social stream, please wait...

View Full RCUS Social Stream

RCUS Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Continue Researching RCUS

Want to see what other sources are saying about Arcus Biosciences Inc's financials and stock price? Try the links below:

Arcus Biosciences Inc (RCUS) Stock Price | Nasdaq
Arcus Biosciences Inc (RCUS) Stock Quote, History and News - Yahoo Finance
Arcus Biosciences Inc (RCUS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!